Literature DB >> 28870557

Retroviral envelope proteins: Involvement in neuropathogenesis.

Dorte Tranberg Hansen1, Thor Petersen2, Tove Christensen3.   

Abstract

The primary disease caused by infection with the exogenous human retroviruses, human immunodeficiency virus 1 (HIV-1) or human T-cell lymphotropic virus 1 (HTLV-1), may overlay manifestations of additional autoimmune pathogenesis. Currently, a role for human endogenous retroviruses (HERVs) is also emerging in some autoimmune/immune-mediated diseases, particularly in multiple sclerosis (MS). Both exogenous and endogenous retroviruses have the potential to elicit the processes leading to autoimmune disease. The pathogenicity of the retroviral envelope protein (Env) is a key player with notable importance in neuroimmune diseases. An essential prerequisite of retroviral infection is the interactions between Env (the retroviral adhesion) proteins on the virion and specific surface receptors on the host cell. These interactions facilitate fusion of the viral envelope and cellular membranes. Additional fusiogenic activities mediated by Env may be beneficial (establishment of the syncytiotrophoblast induced by a HERV-encoded Env) or detrimental to the host (syncytia formation, induction of apoptosis), and Envs are further implied in the direct induction of proinflammatory cytokines, the regulation of autophagy, and pathways of cell death. The pathogenic potential of retroviral Env is therefore not limited to the pathogenetics of infection but also comprise the pathogenic/toxic capacity of the Env protein itself.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Envelope protein; Human T-cell lymphotropic virus 1; Human endogenous retroviruses; Human immunodeficiency virus 1; Neuropathogenesis

Mesh:

Substances:

Year:  2017        PMID: 28870557     DOI: 10.1016/j.jns.2017.07.027

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

Review 1.  Human Endogenous Retroviruses and Their Putative Role in the Development of Autoimmune Disorders Such as Multiple Sclerosis.

Authors:  Victoria Gröger; Holger Cynis
Journal:  Front Microbiol       Date:  2018-02-20       Impact factor: 5.640

2.  Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis.

Authors:  Mikkel Carstensen Gjelstrup; Morten Stilund; Thor Petersen; Holger Jon Møller; Eva Lykke Petersen; Tove Christensen
Journal:  Immunol Cell Biol       Date:  2017-12-11       Impact factor: 5.126

3.  Anti-HERV-WEnv antibodies are correlated with seroreactivity against Mycobacterium avium subsp. paratuberculosis in children and youths at T1D risk.

Authors:  Magdalena Niegowska; Małgorzata Wajda-Cuszlag; Grażyna Stępień-Ptak; Joanna Trojanek; Jacek Michałkiewicz; Mieczysław Szalecki; Leonardo A Sechi
Journal:  Sci Rep       Date:  2019-04-18       Impact factor: 4.379

Review 4.  Epstein-Barr Virus and Neurological Diseases.

Authors:  Nan Zhang; Yuxin Zuo; Liping Jiang; Yu Peng; Xu Huang; Lielian Zuo
Journal:  Front Mol Biosci       Date:  2022-01-10

Review 5.  Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Authors:  Leoni Rolfes; Marc Pawlitzki; Steffen Pfeuffer; Niklas Huntemann; Heinz Wiendl; Tobias Ruck; Sven G Meuth
Journal:  BioDrugs       Date:  2020-10       Impact factor: 5.807

6.  Formation of HERV-K and HERV-Fc1 Envelope Family Members is Suppressed on Transcriptional and Translational Level.

Authors:  Victoria Gröger; Lisa Wieland; Marcel Naumann; Ann-Christin Meinecke; Beate Meinhardt; Steffen Rossner; Christian Ihling; Alexander Emmer; Martin S Staege; Holger Cynis
Journal:  Int J Mol Sci       Date:  2020-10-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.